Associations of erythrocyte omega-3 fatty acids with cognition, brain imaging and biomarkers in the Alzheimer's Disease Neuroimaging Initiative - Université de Rennes Accéder directement au contenu
Article Dans Une Revue The American Journal of Clinical Nutrition Année : 2022

Associations of erythrocyte omega-3 fatty acids with cognition, brain imaging and biomarkers in the Alzheimer's Disease Neuroimaging Initiative

Résumé

Background: The association between omega-3 (ω-3) PUFAs and cognition, brain imaging and biomarkers is still not fully established. Objectives: The aim was to analyze the cross-sectional and retrospective longitudinal associations between erythrocyte ω-3 index and cognition, brain imaging, and biomarkers among older adults. Methods: A total of 832 Alzheimer's Disease Neuroimaging Initiative 3 (ADNI-3) participants, with a mean (SD) age of 74.0 (7.9) y, 50.8% female, 55.9% cognitively normal, 32.7% with mild cognitive impairment, and 11.4% with Alzheimer disease (AD) were included. A low ω-3 index (%EPA + %DHA) was defined as the lowest quartile (≤3.70%). Cognitive tests [composite score, AD Assessment Scale Cognitive (ADAS-Cog), Wechsler Memory Scale (WMS), Trail Making Test, Category Fluency, Mini-Mental State Examination, Montreal Cognitive Assessment] and brain variables [hippocampal volume, white matter hyperintensities (WMHs), positron emission tomography (PET) amyloid-β (Aβ) and tau] were considered as outcomes in regression models. Results: Low ω-3 index was not associated with cognition, hippocampal, and WMH volume or brain Aβ and tau after adjustment for demographics, ApoEε4, cardiovascular disease, BMI, and total intracranial volume in the cross-sectional analysis. In the retrospective analysis, low ω-3 index was associated with greater Aβ accumulation (adjusted β = 0.02; 95% CI: 0.01, 0.03; P = 0.003). The composite cognitive score did not differ between groups; however, low ω-3 index was significantly associated with greater WMS-delayed recall cognitive decline (adjusted β = -1.18; 95% CI: -2.16, -0.19; P = 0.019), but unexpectedly lower total ADAS-Cog cognitive decline. Low ω-3 index was cross-sectionally associated with lower WMS performance (adjusted β = -1.81, SE = 0.73, P = 0.014) and higher tau accumulation among ApoE ε4 carriers. Conclusions: Longitudinally, low ω-3 index was associated with greater Aβ accumulation and WMS cognitive decline but unexpectedly with lower total ADAS-Cog cognitive decline. Although no associations were cross-sectionally found in the whole population, low ω-3 index was associated with lower WMS cognition and higher tau accumulation among ApoE ε4 carriers. The Alzheimer's Disease Neuroimaging Initiative (ADNI) is registered at clinicaltrials.gov as NCT00106899.
Fichier principal
Vignette du fichier
Rouch et al - 2023 - Associations of erythrocyte omega-3 fatty acids.pdf (1.03 Mo) Télécharger le fichier
Rouch_nqac236_supplemental_file.pdf (866.67 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-04099032 , version 1 (16-05-2023)

Licence

Paternité - Pas d'utilisation commerciale

Identifiants

Citer

Laure Rouch, Kelly Virecoulon Giudici, Christelle Cantet, Sophie Guyonnet, Julien Delrieu, et al.. Associations of erythrocyte omega-3 fatty acids with cognition, brain imaging and biomarkers in the Alzheimer's Disease Neuroimaging Initiative: crosssectional and longitudinal retrospective analyses. The American Journal of Clinical Nutrition, 2022, 116 (6), pp.1492-1506. ⟨10.1093/ajcn/nqac236⟩. ⟨hal-04099032⟩
57 Consultations
197 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More